在2型糖尿病中使用移动应用程序来改善药物坚持和糖化血红蛋白的影响:一项前后研究
Fatemeh Bakhtiari1, Firozeh Sajedi2, Maryam Etminaniesfahani3
1School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.
The International journal of risk & safety in medicine
|September 11, 2025
概括
一个移动应用程序显著改善了2型糖尿病患者的药物坚持. 虽然HbA1c水平略有下降,但没有临床意义,这表明该应用程序对坚持有效,但不能控制血糖.
科学领域:
- 内分泌学 在内分泌学.
- 数字健康数字健康
- 行为科学 行为科学
背景情况:
- 药物坚持对于有效的糖尿病管理至关重要.
- 许多患有2型糖尿病的患者在持续坚持口服药物治疗方面遇到困难.
- 坚持不良会对治疗结果和血糖控制产生负面影响.
研究的目的:
- 评估移动应用程序在提高药物服药的有效性.
- 评估移动应用程序对2型糖尿病患者的糖化血红蛋白 (HbA1c) 水平的影响.
- 为了确定一个移动应用程序是否可以改善患者使用口服糖尿病药物的坚持和血糖控制.
主要方法:
- 一项随机对照试验,涉及60名2型糖尿病患者.
- 干预小组使用了一个移动应用程序,带有定时音频报警和动画来提醒药物.
- 对照组接受了标准护理;在三个月内测量了药物坚持和HbA1c.
主要成果:
- 干预组在所有测量时间点 (p=0.00) 上表现出显著更高的药物坚持.
- 在干预组 (p=0.02) 观察到HbA1c的统计显著降低0.28%.
- 移动应用程序干预导致与对照组相比,遵守的平均排名差异.
结论:
- 移动应用程序显示承诺作为一种工具,以改善2型糖尿病的药物坚持.
- 虽然坚持改善了,但观察到的HbA1c的减少不被认为具有临床意义.
- 可能需要进一步的研究来优化数字健康干预措施,以全面管理糖尿病.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.4K
Oral Hypoglycemic Agents: Biguanides and Glitazones
588
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
588
Diabetes: Management and Pharmacotherapy
870
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
870
Insulin: Dosing Regimen and Adverse Effects
695
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
695
Carbohydrate Metabolism
13.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.8K
Dipeptidyl Peptidase 4 Inhibitors
598
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
598


